|
Volumn 22, Issue 12, 2008, Pages 1514-1516
|
Safety of etanercept therapy in a patient with psoriasis, Down's syndrome and concomitant hepatitis C virus infection
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ETANERCEPT;
ADULT;
CASE REPORT;
DOWN SYNDROME;
DRUG EFFECT;
DRUG SAFETY;
DRUG TOLERABILITY;
HEPATITIS C;
HUMAN;
LETTER;
LIVER FUNCTION;
MALE;
PHYSICAL EXAMINATION;
PRIORITY JOURNAL;
PSORIASIS;
TREATMENT CONTRAINDICATION;
VIRUS LOAD;
ADULT;
DOWN SYNDROME;
HEPATITIS C;
HUMANS;
IMMUNOGLOBULIN G;
IMMUNOSUPPRESSIVE AGENTS;
MALE;
PSORIASIS;
RECEPTORS, TUMOR NECROSIS FACTOR;
TREATMENT OUTCOME;
|
EID: 56549091690
PISSN: 09269959
EISSN: 14683083
Source Type: Journal
DOI: 10.1111/j.1468-3083.2008.02693.x Document Type: Letter |
Times cited : (13)
|
References (6)
|